Chair and Department of Pharmaceutical Botany, Jagiellonian University, Collegium Medicum, ul. Medyczna 9, 30-688 Kraków, Poland.
Chair and Department of Pharmaceutical Botany, Jagiellonian University, Collegium Medicum, ul. Medyczna 9, 30-688 Kraków, Poland.
J Biotechnol. 2019 Nov 10;305:61-70. doi: 10.1016/j.jbiotec.2019.08.021. Epub 2019 Sep 5.
In vitro cultures and raw materials (fruits and leaves) of the valuable medicinal plant species - Schisandra chinensis cultivar Sadova No. 1 (SchS) - were evaluated for the production of two groups of phenolic compounds, phenolic acids and flavonoids, and their antioxidant potential. A series of experiments was conducted, aimed at optimizing culture conditions for maximum growth and phenolic production in SchS microshoots. Different concentrations of plant growth regulators (6-benzyladenine - BA and 1-naphthaleneacetic acid - NAA, from 0 to 3 mg/l) in Murashige-Skoog (MS) medium were tested in several cultivation systems (agar, agitated, bioreactor) over various growth periods (10, 20, 30, 40, 50 and 60 days). Furthermore, an elicitation experiment was conducted in which the bioreactor-grown microshoots were exposed to yeast extract. HPLC-DAD analyses confirmed the presence of eight phenolic acids - chlorogenic, cryptochlorogenic, gallic, neochlorogenic, protocatechuic, salicylic, syringic and vanillic, and two flavonoids: kaempferol and quercitrin, in the in vitro biomasses. The highest total phenolic acid (357.93 mg/100 g DW) and flavonoid (105.07 mg/100 g DW) contents were obtained in agar culture extracts cultivated for 30 days on MS medium containing 2 mg/l BA and 0.5 mg/l NAA and for 50 days on MS medium containing 0.1 mg/l BA and 2 mg/l NAA, respectively. These amounts were 1.59- and 5.95-fold lower than in parent plant leaf extracts (569.66 mg/100 g DW), and 4.30- and 1.25-fold higher than in fruit extracts (83.17 mg/100 g DW), respectively. Microshoots grown in a Plantform bioreactor also proved to be a good source of phenolic compounds, however, the elicitor treatment had no noticeable effect on their accumulation. Antioxidant capacity assessed by the Folin-Ciocalteu, FRAP, DPPH and CUPRAC assays revealed significantly higher potential in extracts from in vitro biomass and leaves of the parent plant, as compared to the parent plant fruit extracts.
对有价值药用植物物种——中华五味子栽培品种 Sadova No.1(SchS)的体外培养物和原材料(果实和叶片)进行了评估,以研究两组酚类化合物,即酚酸和类黄酮,以及它们的抗氧化潜力。进行了一系列实验,旨在优化 SchS 微茎段的最大生长和酚类生产的培养条件。在几种培养系统(琼脂、搅拌、生物反应器)中,测试了不同浓度的植物生长调节剂(6-苄基腺嘌呤-BA 和 1-萘乙酸-NAA,从 0 到 3mg/l)在 Murashige-Skoog(MS)培养基中的作用,培养时间(10、20、30、40、50 和 60 天)不同。此外,还进行了诱导实验,其中生物反应器中生长的微茎段暴露于酵母提取物中。HPLC-DAD 分析证实,在体外生物量中存在八种酚酸——绿原酸、隐绿原酸、没食子酸、新绿原酸、原儿茶酸、水杨酸、丁香酸和香草酸,以及两种类黄酮:山奈酚和槲皮素。在琼脂培养物提取物中,总酚酸(357.93mg/100g DW)和类黄酮(105.07mg/100g DW)含量最高,在含有 2mg/l BA 和 0.5mg/l NAA 的 MS 培养基中培养 30 天,在含有 0.1mg/l BA 和 2mg/l NAA 的 MS 培养基中培养 50 天。这些含量分别比亲本植物叶片提取物(569.66mg/100g DW)低 1.59-5.95 倍,比果实提取物(83.17mg/100g DW)高 4.30-1.25 倍。在 Plantform 生物反应器中生长的微茎段也被证明是酚类化合物的良好来源,但诱导剂处理对其积累没有明显影响。通过福林-肖卡、FRAP、DPPH 和 CUPRAC 测定评估的抗氧化能力表明,与亲本植物果实提取物相比,体外生物量和亲本植物叶片提取物的潜力显著更高。